Incontinentia pigmenti: a rare X-linked genodermatosis. A case report
Main Article Content
Abstract
Incontinentia pigmenti (Bloch-Sulzberger Syndrome) is a rare genodermatosis. The disease is X-linked and the most common molecular defect includes mutations in the NEMO gene on chromosome Xq28 in approximately 70% of patients. It is characterized by a multisystem compromise in which the skin manifestations occur in all patients. Also, the dermatological findings occur early and in chronological order. The prevalence of extra skin compromise is approximately 80% of patients. The ophthalmological and neurological manifestations are the major cause of disability in patients and may have a great impact on the quality of life. Some of damages are irreversible. We present the clinical case of a child on her first day of life. It began with skin manifestations typical of incontinentia pigmenti and extensive neurological involvement. In addition, the family history includes a sister with the disease. A multidisciplinary approach is necessary to care for patients and to detect and prevent long-term complications.
Article Details
References
Poziomczyk CS, Recuero JK, Bringhenti L, Maria FDS, Campos CW, Travi GM, et al. Incontinentia pigmenti. An Bras Dermatol. 2014; 89(1): 26–36.
Yang Y, Guo Y, Ping Y, Zhou X-G, Li Y. Neonatal incontinentia pigmenti: Six cases and a literature review. Exp Ther Med. 2014; 8(6): 1797–1806.
Marques GF, Tonello CS, Sousa JMP. Incontinentia pigmenti or Bloch-Sulzberger syndrome: A rare X-linked genodermatosis. An Bras Dermatol. 2014; 89(3): 486–489.
Enei L, Orellana I, Vargas X, Salazar R, Paschoal F. Incontinencia pigmenti en madre e hija. Relato de caso clínico. Rev Chil Pediatr. 2011; 82(3): 225-230.
Welch JL, Jimenez HL, Allen SE. Pediatric rash: dermatologic manifestations of incontinentia pigmenti. J Emerg Med. 2013; 45(2): e41–3.
Meuwissen MEC, Mancini GMS. Neurological findings in incontinentia pigmenti; a review. Eur J Med Genet. 2012; 55(5): 323–331.
